title: HIF-2alpha regulates murine hematopoietic development in an erythropoietin-dependent manner.
abstract: Erythropoiesis in the adult mammal depends critically on erythropoietin, an inducible cytokine with pluripotent effects. Erythropoietin gene expression increases under conditions associated with lowered oxygen content such as anemia and hypoxia. HIF-1alpha, the founding member of the hypoxia-inducible factor (HIF) alpha class, was identified by its ability to bind and activate the hypoxia-responsive enhancer in the erythropoietin regulatory region in vitro. The existence of multiple HIF alpha members raises the question of which HIF alpha member or members regulates erythropoietin expression in vivo. We previously reported that mice lacking wild-type HIF-2alpha, encoded by the EPAS1 gene, exhibit pancytopenia. In this study, we have characterized the etiology of this hematopoietic phenotype. Molecular studies of EPAS1-null kidneys reveal dramatically decreased erythropoietin gene expression. EPAS1-null as well as heterozygous mice have impaired renal erythropoietin induction in response to hypoxia. Treatment of EPAS1-null mice with exogenous erythropoietin reverses the hematopoietic and other defects. We propose that HIF-2alpha is an essential regulator of murine erythropoietin production. Impairments in HIF signaling, involving either HIF-1alpha or HIF-2alpha, may play a prominent role in conditions involving altered hematopoietic or erythropoietin homeostasis.
authors.affiliation: Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390-8573, USA.
authors.forename: Marzia
authors.initials: M
authors.lastname: Scortegagna
authors.forename: Kan
authors.initials: K
authors.lastname: Ding
authors.forename: Quiyang
authors.initials: Q
authors.lastname: Zhang
authors.forename: Yavuz
authors.initials: Y
authors.lastname: Oktay
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Bennett
authors.forename: Michael
authors.initials: M
authors.lastname: Bennett
authors.forename: John M
authors.initials: JM
authors.lastname: Shelton
authors.forename: James A
authors.initials: JA
authors.lastname: Richardson
authors.forename: Orson
authors.initials: O
authors.lastname: Moe
authors.forename: Joseph A
authors.initials: JA
authors.lastname: Garcia
mesh_terms: D000818:Animals; D051792:Basic Helix-Loop-Helix Proteins; D004921:Erythropoietin / Q000235:genetics*; D005260:Female; D015870:Gene Expression; D006410:Hematopoiesis / Q000502:physiology*; D000860:Hypoxia / Q000503:physiopathology; D007668:Kidney / Q000502:physiology; D008297:Male; D051379:Mice; D008817:Mice, Mutant Strains; D010198:Pancytopenia / Q000378:metabolism / Q000503:physiopathology*; D010641:Phenotype; D012333:RNA, Messenger / Q000032:analysis; D015534:Trans-Activators / Q000235:genetics* / Q000378:metabolism*; D000099162:Endothelial PAS Domain-Containing Protein 1
chemical_list: D051792:Basic Helix-Loop-Helix Proteins; D004921:Erythropoietin; D012333:RNA, Messenger; D015534:Trans-Activators; D000099162:Endothelial PAS Domain-Containing Protein 1